Abstract
Substantial evidence now supports the view that epigenetic changes have a role in the development of human prostate cancer. Analyses of the patterns of epigenetic alteration are providing important insights into the origin of this disease and have identified specific alterations that may serve as useful diagnostic and prognostic biomarkers. Examination of cancer methylation patterns supports a stem cell origin of prostate cancer. It is well established that methylation of GSTpi is a marker of prostate cancer, and global patterns of histone marking appear to be linked to cancer prognosis with levels of acetylated histones H3K9, H3K18, and H4K12, and of dimethylated H4R3 and H3K4, dividing low-grade prostate cancer (Gleason 6 or less) into two prognostically separate groups. Elevated levels of several components of the polycomb group protein complex, EZH2, BMI1, and RING1, can also act as biomarkers of poor clinical outcome. Many components of the epigenetic machinery, including histone deacetylase (whose expression level is linked to the TMPRSS2:ERG translocation) and the histone methylase EZH2, are potential therapeutic targets. The recent discovery of the role of small RNAs in governing the epigenetic status of individual genes offers exciting new possibilities in therapeutics and chemoprevention.
Keywords
EpigeneticsProstate cancerTMPRSS2EZH2BiologyHistoneCancerHistone deacetylaseCancer researchDNA methylationProstateEpigenomicsBioinformaticsGeneticsDiseaseMedicineInternal medicineGene expressionGene
Affiliated Institutions
Related Publications
Histone acetylation and an epigenetic code
The enzyme-catalyzed acetylation of the N-terminal tail domains of core histones provides a rich potential source of epigenetic information. This may be used both to mediate tra...
Translating the Histone Code
Chromatin, the physiological template of all eukaryotic genetic information, is subject to a diverse array of posttranslational modifications that largely impinge on histone ami...
NCBI Epigenomics: a new public resource for exploring epigenomic data sets
The Epigenomics database at the National Center for Biotechnology Information (NCBI) is a new resource that has been created to serve as a comprehensive public resource for whol...
Hallmarks of Cancer: New Dimensions
Abstract The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying...
Discerning the Ancestry of European Americans in Genetic Association Studies
European Americans are often treated as a homogeneous group, but in fact form a structured population due to historical immigration of diverse source populations. Discerning the...
Publication Info
- Year
- 2008
- Type
- review
- Volume
- 100
- Issue
- 2
- Pages
- 240-245
- Citations
- 105
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
105
OpenAlex
Cite This
Christopher S. Cooper,
Christopher S. Foster
(2008).
Concepts of epigenetics in prostate cancer development.
British Journal of Cancer
, 100
(2)
, 240-245.
https://doi.org/10.1038/sj.bjc.6604771
Identifiers
- DOI
- 10.1038/sj.bjc.6604771